Are Markets Finally Starting To See Intra-Cellular Therapies, Inc. (ITCI)’s Billion-Dollar Potential?

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) just announced that it has kicked off a phase 3 clinical trial for its lead neurological candidate, ITI-007-201.

Keep Reading →